Testing effectiveness (Phase 2)Study completedNCT04457310
What this trial is testing
A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia
Who this might be right for
Early Course Schizophrenia Spectrum Disorder
Yale University 112